Update on phase 2b trial of MN-166 (ibudilast)....
Posted: Tue Sep 23, 2014 11:59 pm
Update on phase 2b trial of MN-166 (ibudilast) in progressive MS
MediciNova, Inc. has announced that, as of September 15, 2014, the ongoing Phase 2b trial of MN-166 (ibudilast) in progressive multiple sclerosis (MS) had enrolled 150 of the 250 subjects planned to be enrolled. Enrollment is expected to be completed during the first quarter of 2015........ Read more - http://www.ms-uk.org/MN-166
MediciNova, Inc. has announced that, as of September 15, 2014, the ongoing Phase 2b trial of MN-166 (ibudilast) in progressive multiple sclerosis (MS) had enrolled 150 of the 250 subjects planned to be enrolled. Enrollment is expected to be completed during the first quarter of 2015........ Read more - http://www.ms-uk.org/MN-166